Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 15;92(3):134-144.
doi: 10.1212/WNL.0000000000006697. Epub 2018 Dec 26.

Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list

Affiliations
Review

Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list

Thien Phu Do et al. Neurology. .

Abstract

A minority of headache patients have a secondary headache disorder. The medical literature presents and promotes red flags to increase the likelihood of identifying a secondary etiology. In this review, we aim to discuss the incidence and prevalence of secondary headaches as well as the data on sensitivity, specificity, and predictive value of red flags for secondary headaches. We review the following red flags: (1) systemic symptoms including fever; (2) neoplasm history; (3) neurologic deficit (including decreased consciousness); (4) sudden or abrupt onset; (5) older age (onset after 65 years); (6) pattern change or recent onset of new headache; (7) positional headache; (8) precipitated by sneezing, coughing, or exercise; (9) papilledema; (10) progressive headache and atypical presentations; (11) pregnancy or puerperium; (12) painful eye with autonomic features; (13) posttraumatic onset of headache; (14) pathology of the immune system such as HIV; (15) painkiller overuse or new drug at onset of headache. Using the systematic SNNOOP10 list to screen new headache patients will presumably increase the likelihood of detecting a secondary cause. The lack of prospective epidemiologic studies on red flags and the low incidence of many secondary headaches leave many questions unanswered and call for large prospective studies. A validated screening tool could reduce unneeded neuroimaging and costs.

PubMed Disclaimer

References

    1. Eller M, Goadsby PJ. MRI in headache. Expert Rev Neurother 2013;13:263–273. - PubMed
    1. Jordan JE, Ramirez GF, Bradley WG, Chen DY, Lightfoote JB, Song A. Economic and outcomes assessment of magnetic resonance imaging in the evaluation of headache. J Natl Med Assoc 2000;92:573–578. - PMC - PubMed
    1. Niessen WJ, Breteler MMB, Van der Lugt A. Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821–1828. - PubMed
    1. Sobri M, Lamont AC, Alias NA, Win MN. Red flags in patients presenting with headache: clinical indications for neuroimaging. Br J Radiol 2003;76:532–535. - PubMed
    1. Christiaans MH, Kelder JC, Arnoldus EPJ, Tijssen CC. Prediction of intracranial metastases in cancer patients with headache. Cancer 2002;94:2063–2068. - PubMed

Publication types